CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders

Astrocytic impairment is a pathologic feature of neuromyelitis optica spectrum disorder (NMOSD). S100B and glial fibrillary acidic protein (GFAP) are the two most commonly used astrocytic markers. The aim of this study was to evaluate whether CSF-S100B could serve as a marker of NMOSD. We enrolled 4...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Biomed Res Int
Auteurs principaux: Wei, Yuzhen, Chang, Haoxiao, Li, Xindi, Du, Li, Xu, Wangshu, Cong, Hengri, Yao, Yajun, Zhang, Xinghu, Yin, Linlin
Format: Artigo
Langue:Inglês
Publié: Hindawi 2018
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217894/
https://ncbi.nlm.nih.gov/pubmed/30426010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/5381239
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires